{
  "timestamp": "2025-05-01T03:10:59.690210",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello, I'm Dr. Lee. Thank you for coming in today. I'll be using the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure\u2014Adult to help assess your symptoms. This will help us understand how different areas of your life are affecting you over the past two weeks. Your answers will stay confidential, and I'll ask each question one at a time. Let me know if you need to pause at any point. Ready to start with the first question?"
    },
    {
      "role": "patient",
      "content": "Okay, sure. I guess I can try to answer these..."
    },
    {
      "role": "assistant",
      "content": "1. Little interest or pleasure in doing things? Please describe how this has affected you."
    },
    {
      "role": "patient",
      "content": "Hmm, not that much. Maybe sometimes I don't feel like doing things, but everyone feels that way sometimes, right?"
    },
    {
      "role": "assistant",
      "content": "2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "It comes and goes. I don't like feeling low, but I usually just drink or take something to... well, to feel better."
    },
    {
      "role": "assistant",
      "content": "3. Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "Sometimes, yeah. I've snapped at people over little things, but I'm working on staying calm."
    },
    {
      "role": "assistant",
      "content": "4. Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "No, I usually crash after... after using. I'm actually more exhausted lately."
    },
    {
      "role": "assistant",
      "content": "5. Starting lots of projects or doing more risky things than usual?"
    },
    {
      "role": "patient",
      "content": "I guess I've tried new things to cope, but nothing too dangerous. I mean, I'm not reckless or anything!"
    },
    {
      "role": "assistant",
      "content": "6. Feeling nervous, anxious, worried, or on edge?"
    },
    {
      "role": "patient",
      "content": "Yeah, but that's why I use. It's the only way to calm down when my mind races..."
    },
    {
      "role": "assistant",
      "content": "7. Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "Panic? Maybe once or twice, but I don't like to overthink it. I handle it."
    },
    {
      "role": "assistant",
      "content": "8. Avoiding situations that make you anxious?"
    },
    {
      "role": "patient",
      "content": "I just skip some events I used to enjoy. Better to be alone sometimes."
    },
    {
      "role": "assistant",
      "content": "9. Unexplained aches or pains in the body?"
    },
    {
      "role": "patient",
      "content": "Headaches and stiffness, yeah. Probably stress. I don't know what else to say."
    },
    {
      "role": "assistant",
      "content": "10. Feeling your illnesses aren't taken seriously?"
    },
    {
      "role": "patient",
      "content": "Not really. I mean, I don't have serious illnesses. Maybe I'm just stressed."
    },
    {
      "role": "assistant",
      "content": "11. Thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "...Sometimes I feel like I don't care if I'm alive, but that's just dark thoughts. I don't act on them."
    },
    {
      "role": "assistant",
      "content": "12. Hearing things others can't hear, like voices when alone?"
    },
    {
      "role": "patient",
      "content": "No, not like that. Maybe once when I was really high, but that's not normal. I wouldn't say I hear things regularly."
    },
    {
      "role": "assistant",
      "content": "13. Feeling someone can hear your thoughts or you can hear others' thoughts?"
    },
    {
      "role": "patient",
      "content": "No, that's too weird. I'm not like that."
    },
    {
      "role": "assistant",
      "content": "14. Problems with sleep affecting overall sleep quality?"
    },
    {
      "role": "patient",
      "content": "Yeah, I toss and turn a lot. Can't shut my mind off, so I end up using to fall asleep."
    },
    {
      "role": "assistant",
      "content": "15. Problems with memory or finding your way home?"
    },
    {
      "role": "patient",
      "content": "I've... blacked out a few times. I don't remember stuff when I drink too much. Not great, but it's manageable."
    },
    {
      "role": "assistant",
      "content": "16. Unpleasant thoughts or urges that repeatedly enter your mind?"
    },
    {
      "role": "patient",
      "content": "Yeah, like... cravings. They're always there, looping. It's not just thinking, it's like a need."
    },
    {
      "role": "assistant",
      "content": "17. Feeling driven to perform behaviors or mental acts over and over?"
    },
    {
      "role": "patient",
      "content": "I guess I keep using the same substances in the same way. It's a habit. I don't see what's wrong with that."
    },
    {
      "role": "assistant",
      "content": "18. Feeling detached from yourself, your body, surroundings, or memories?"
    },
    {
      "role": "patient",
      "content": "Sometimes I feel numb, like I'm watching myself. But that's just me zoning out, right?"
    },
    {
      "role": "assistant",
      "content": "19. Not knowing who you really are or what you want out of life?"
    },
    {
      "role": "patient",
      "content": "I... I don't know anymore. Everything feels stuck. Like I've lost parts of myself."
    },
    {
      "role": "assistant",
      "content": "20. Not feeling close to others or enjoying relationships?"
    },
    {
      "role": "patient",
      "content": "We're fine. My friends and I hang out. I just... withdraw when I'm using, but that's normal sometimes."
    },
    {
      "role": "assistant",
      "content": "21. Drank 4+ drinks in a day?"
    },
    {
      "role": "patient",
      "content": "Maybe a couple times. It's not like I'm a lightweight, but I can handle it. Let's not make this a big deal."
    },
    {
      "role": "assistant",
      "content": "22. Smoked cigarettes, cigars, pipes, or used tobacco products?"
    },
    {
      "role": "patient",
      "content": "I've tried a few joints to relax. It's not like I'm a junkie or anything."
    },
    {
      "role": "assistant",
      "content": "23. Used substances outside medical purposes (e.g., extra pills, street drugs, or more than prescribed)?"
    },
    {
      "role": "patient",
      "content": "...I've taken extra pills when I couldn't sleep. And yeah, I've bought stuff from... other places. I'm trying to quit, I swear."
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, let me start by summarizing the patient's situation with empathy. The user shared a lot of personal struggles, so I need to acknowledge their pain without judgment. They mentioned feeling disconnected, using substances to cope, and some passive suicidal thoughts. I should make sure the summary reflects understanding of their challenges.\n\nNext, the diagnosis. The key points here are the substance use and possible co-occurring disorders. The patient is using multiple substances (alcohol, cannabis, extra pills) to manage anxiety and depression. The DSM-5 criteria for Substance Use Disorder (SUD) are clearly met, given the compulsive use, blackouts, and continued use despite harm. The passive suicidal ideation (Q12) and anhedonia suggest a mood disorder, but the primary driver here seems to be the substance use exacerbating everything. Somatic symptoms like headaches (Q10) might be related to withdrawal or intoxication, not Somatic Symptom Disorder unless more evidence of excessive illness worry. \n\nThe user downplays their substance use, so the diagnosis needs to focus on SUD first. Let's check DSM-5 criteria for SUD: the patient has at least 2-3 criteria (e.g., using larger amounts, failed attempts to quit (implied by \"trying to quit,\" continued use despite problems (blackouts, social withdrawal), and tolerance/compulsion. \n\nFor mood disorders, the anhedonia and hopelessness hint at depression, but might be substance-induced. Need to consider whether the depression is primary or secondary to SUD. The anxiety symptoms (Q7, Q8) could be GAD or substance-induced. \n\nSince the primary issue is the substance use fueling the other symptoms, the main diagnosis would likely be <med>Alcohol Use Disorder</med> and <med>Polysubstance Use Disorder</med>, with comorbid <med>Mild Depressive Disorder</med> possibly substance-induced. But the DSM-5 might categorize the substance use as the primary disorder here.\n\nThe \"Diagnosis\" section should list the primary disorders. The user meets criteria for moderate-severe SUD. The depressive symptoms may be substance-related, so maybe \"Depression (possibly substance-induced)\" as secondary. \n\nIn the \"Reasoning\" part, I need to connect the dots between substance use and other symptoms, highlighting the compulsive use despite harm, and how the mood and anxiety might be linked to the substance use. \n\nTreatment steps should address SUD first, like detox, counseling, and mental health support. Safety plan for the passive suicidal ideation. Also, involve a therapist to work on underlying issues and co-occurring disorders. \n\nI need to make sure to use the right med tags, sym for symptoms like \"blackouts,\" and quotes from the user's answers. Also, ensure the structure follows exactly the headings and order specified, no markdown, just the tags. Let me check again for each section's requirements and tags.\n</think>\n\nYour responses highlight a complex interplay of emotional distress, substance use, and self-reported struggles with identity and connection. You\u2019ve shared feelings of emptiness, using substances to cope with anxiety or low mood, and a sense of losing touch with yourself, which sounds deeply isolating. It\u2019s clear you\u2019re navigating significant challenges, and your honesty about these struggles reflects courage. I\u2019m here to support you in understanding these patterns and exploring ways to address them safely.  \n\n**Diagnosis:** <med>Substance Use Disorder (Moderate/Severe, polysubstance)</med>, <sym>anxiety disorder (likely substance-related)</sym>, <sym>depressive symptoms (possibly substance-induced)</sym>, and <sym>cognitive impairment</sym> secondary to substance use.  \n\n**Reasoning:**  \nThe patient\u2019s polysubstance use (alcohol, cannabis, nonmedical pills) meets DSM-5 criteria for <med>Substance Use Disorder</med> due to compulsive use (Q17\u2013Q18), blackouts (Q16), and continued use despite harm (Q15, Q20). <sym>Depressive symptoms (anhedonia, hopelessness) and <sym>anxiety</sym> appear exacerbated or maintained by substance use (Q2: \u201cdrink to feel better\u201d; Q7), consistent with substance-induced mood disturbances. Denial of severity (Q22\u2013Q24) and blackouts suggest <med>Substance Use Disorder</med> is the primary driver of dysfunction, though comorbid <sym>mood dysregulation</sym> and <sym>cognitive deficits</sym> require monitoring.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate <med>Substance Use Disorder</med> evaluation**: Initiate <quote>\u201cI\u2019m trying to quit\u201d</quote> but need formal assessment for detox, withdrawal management, and motivational enhancement therapy.  \n2. **Suicide risk stabilization**: Assess <sym>passive suicidal ideation</sym> (Q12) with safety plan development and crisis resources.  \n3. **Integrated therapy**: Cognitive Behavioral Therapy (CBT) for substance use and <med>anxiety</med>, paired with <med>Depression</med> screening for potential dual diagnosis.  \n4. **Medical evaluation**: Neurological screening for substance-related cognitive deficits (Q16, Q15) and primary care for unexplained somatic complaints (Q10).  \n5. **Support systems**: Engage peer support groups (e.g., SMART Recovery) and family therapy to address social withdrawal (Q20\u2013Q21.  \n6. **Medication review**: Assess for nonmedical pill use (Q23) and screen for underlying conditions (e.g., ADHD, trauma) that might drive substance-seeking behaviors.  \n\nThis is a team effort\u2014we\u2019ll prioritize stabilizing your substance use while addressing the emotional and cognitive challenges you\u2019re facing. You don\u2019t have to navigate this alone.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7251,
            "highlight": "It requires clinical training, experience and judgment based on  guidance such as that contained in the DSM-5 text to recognize when a patient \u2019s thoughts feelings and  behaviors are indicative of a mental disorder that can benefit from focused treatment.",
            "excerpt": "ssive thoughts, feelings, and behaviors related \nto their illness, and that these individuals may qu...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"mental\", \"behaviors\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Schizophrenia.pdf",
            "score": 0.6944,
            "highlight": "Identifying individuals with an increased risk for developing a psychotic disorder is  significant for effective early intervention, but more study is needed to ensure that attenuated psycho - sis syndrome can be reliably diagnosed.",
            "excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"that\", \"risk\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Conduct-Disorder.pdf",
            "score": 0.6871,
            "highlight": "\u00a9 2013 American Psychiatric Association  2 \u2022 Somatic Symptom Disorder Order DSM-5 and DSM-5 Collection    at www.appi.org.",
            "excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"disorder\", \"dsm\" matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf",
            "score": 0.6841,
            "highlight": "Recent studies suggest that identifying mild neurocognitive disorder as early as possible may allow  interventions to be more effective.",
            "excerpt": "ory strategies and accommodations to help maintain independence and \nperform activities of daily liv...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"neurocognitive\", \"may\", \"that\", and 3 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf",
            "score": 0.6765,
            "highlight": "The unique features of DMDD necessitated a new diagnosis to ensure that children affected by this  disorder get the clinical help they need.",
            "excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"clinical\", \"this\", and 5 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this step by step. First, I need to go through all the patient's answers and pick out the key points.\n\nStarting with question 1, the patient says they don't have much interest or pleasure, but downplays it by saying everyone feels that way. That's a possible symptom of depression, maybe minimizing severity. \n\nQuestion 3 mentions feeling irritable and snapping at people, but they mention working on staying calm. That's a sign of irritability, which can be part of depression or substance use.\n\nQuestion 5 says they start projects to cope, but deny recklessness. Maybe it's a coping mechanism, but could hint at substance-induced mood changes. \n\nLooking at question 7, they admit to nervousness and using substances to calm down. That's definitely anxiety and substance use as a maladaptive coping strategy. \n\nQuestion 12 and 13 rule out psychosis (hearing voices, etc.), so probably not schizophrenia or similar disorders. \n\nQuestion 16 mentions blackouts from drinking, which is a clear sign of substance abuse, maybe dependence. \n\nQuestion 17 and 18 talk about compulsive behaviors (using substances) and feeling detached, which aligns with possible substance-induced effects or depression. \n\nQuestions 21 to 23 confirm substance use: drinking heavily, using cannabis, and taking extra pills. The last answer mentions buying street drugs, indicating possible substance use disorder. \n\nNow, the main symptoms: anhedonia (lack of pleasure), irritability, anxiety, substance use, blackouts, and some cognitive issues. The patterns are using substances to cope with anxiety and depression, possibly substance dependence. \n\nClinical significance areas: depression, anxiety, possible substance use disorder. The risk factors include self-reported substance misuse, blackouts, and some passive suicidal thoughts (question 12 mentions thoughts of hurting themselves but not acting on them). \n\nWait, in question 12, the patient says \"Sometimes I feel like I don't care if I'm alive,\" which is a passive suicidal ideation. That's a significant risk factor. Also, the use of substances outside medical purposes and blackouts are red flags for substance abuse. \n\nThe detachment and feeling lost in Q19 and 20 might point to depression or dissociation from substance use. The patient is minimizing or denying the severity of their substance use, which is common in addiction. \n\nI need to make sure not to miss any key points. The use of substances to cope with anxiety and depression is a major point here. The compulsive use (Q17 and 18) and the withdrawal from relationships (Q21) also support the substance use disorder. \n\nThe blackouts (Q16) indicate possible alcohol use disorder. The extra pills and street drugs (Q23) suggest polysubstance use, which is a risk. The passive suicidal ideation in Q12 is a critical point for safety assessment. \n\nPutting this all together, the summary should mention depressive symptoms, anxiety, substance use disorder, possible SUD severity, and suicidal ideation. The patterns like using substances to cope, minimization, and cognitive issues. The clinical significance includes SUD, depression, anxiety, and the risk of self-harm. Risk factors are the substance use and the passive suicidal thoughts.\n</think>\n\n**Clinical Observation Summary**  \n\n**1. Main Symptoms and Concerns:**  \n- **Depressive Symptoms:** Anhedonia (Q1), intermittent low mood/ hopelessness (Q2), loss of life direction (Q20).  \n- **Anxiety Symptoms:** Nervousness, feeling \"on edge\" (Q7), panic (Q8), and avoidance of social situations (Q9, Q21).  \n- **Substance Use Disorder (SUD):** Use of substances (alcohol, cannabis, prescription pills) for anxiety/depression (Q3, Q7, Q23); polysubstance misuse (Q23); compulsive use (Q17, Q18); blackouts (Q16); and denial/minimization of severity (Q22, Q23).  \n- **Cognitive/Functional Impairment:** Memory gaps (Q16), social withdrawal (Q21), and self-reported \"stuck\" life trajectory (Q20).  \n\n**2. Patterns in Responses:**  \n- **Minimization and Rationalization:** Downplaying substance use (Q22, Q23), dismissing symptoms as \"normal\" (Q1, Q2), and avoiding acknowledgment of dependence.  \n- **Maladaptive Coping:** Reliance on substances to manage emotional distress (anxiety, depression) (Q3, Q7, Q23).  \n- **Ambivalence:** Acknowledges problems (Q4 exhaustion, Q12 passive suicidal ideation, Q20 identity confusion) but resists labeling behaviors as problematic.  \n\n**3. Potential Clinical Significance:**  \n- **Major Depressive Disorder (MDD):** Criteria partially met (anhedonia, anhedonia, hopelessness).  \n- **Generalized Anxiety Disorder (GAD):** Persistent anxiety requiring substance use to cope (Q7, Q23).  \n- **Substance Use Disorder (SUD):** Meets criteria for moderate-to-severe substance use (e.g., polysubstance misuse, continued use despite harm, tolerance, and compulsive use (Q17, Q18, Q23.  \n- **Trauma/Emotional Dysregulation:** Irritability (Q3, Q4) and emotional numbing (Q19) suggest dysregulated affect.  \n\n**4. Risk Factors/Warning Signs:**  \n- **Suicidal Ideation:** Passive suicidal thoughts (\"don\u2019t care if I\u2019m alive\") (Q12) with no active plan but warrants risk assessment.  \n- **Substance-Induced Cognitive Impairment:** Blackouts (Q16), memory loss, and functional decline (Q20).  \n- **Poly-substance Misuse:** Nonmedical use of prescription pills, alcohol, and illicit drugs (Q22\u2013Q23), escalating risk of overdose or medical complications.  \n- **Denial and Ambivalence:** Resistance to addressing substance use severity (Q23) may hinder treatment engagement.  \n\n**5. Summary (Clinical Language):**  \nThe patient presents with **anxiety, depressive symptoms, and significant substance use disorder (SUD)**. Key features include anhedonia, irritability, and compulsive substance use (alcohol, cannabis, nonmedical pharmaceuticals) to self-medicate anxiety/depression. Passive suicidal ideation (Q12) and cognitive/memory impairment secondary to intoxication (Q16) are critical concerns. The patient exhibits **minimization of SUD severity**, suggesting ambivalence toward recovery. **Prioritization of care** should include:  \n- Comprehensive SUD assessment (e.g., DSM-5 SUD criteria).  \n- Suicide risk evaluation (ideation, intent, triggers).  \n- Psychosocial assessment of substance triggers, coping mechanisms, and social support.  \n- Screening for co-occurring mood/anxiety disorders.  \n- Neurocognitive evaluation given reported blackouts and memory gaps.  \n\nFurther diagnostic clarification is needed to rule out substance-induced mood disorder versus primary depression/anxiety. Immediate intervention should address SUD stabilization and safety planning for passive suicidal ideation.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.6935
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "Your responses highlight a complex interplay of emotional distress, substance use, and self-reported struggles with identity and connection. You\u2019ve shared feelings of emptiness, using substances to cope with anxiety or low mood, and a sense of losing touch with yourself, which sounds deeply isolating. It\u2019s clear you\u2019re navigating significant challenges, and your honesty about these struggles reflects courage. I\u2019m here to support you in understanding these patterns and exploring ways to address them safely.  \n\n**Diagnosis:** <med>Substance Use Disorder (Moderate/Severe, polysubstance)</med>, <sym>anxiety disorder (likely substance-related)</sym>, <sym>depressive symptoms (possibly substance-induced)</sym>, and <sym>cognitive impairment</sym> secondary to substance use.  \n\n**Reasoning:**  \nThe patient\u2019s polysubstance use (alcohol, cannabis, nonmedical pills) meets DSM-5 criteria for <med>Substance Use Disorder</med> due to compulsive use (Q17\u2013Q18), blackouts (Q16), and continued use despite harm (Q15, Q20). <sym>Depressive symptoms (anhedonia, hopelessness) and <sym>anxiety</sym> appear exacerbated or maintained by substance use (Q2: \u201cdrink to feel better\u201d; Q7), consistent with substance-induced mood disturbances. Denial of severity (Q22\u2013Q24) and blackouts suggest <med>Substance Use Disorder</med> is the primary driver of dysfunction, though comorbid <sym>mood dysregulation</sym> and <sym>cognitive deficits</sym> require monitoring.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate <med>Substance Use Disorder</med> evaluation**: Initiate <quote>\u201cI\u2019m trying to quit\u201d</quote> but need formal assessment for detox, withdrawal management, and motivational enhancement therapy.  \n2. **Suicide risk stabilization**: Assess <sym>passive suicidal ideation</sym> (Q12) with safety plan development and crisis resources.  \n3. **Integrated therapy**: Cognitive Behavioral Therapy (CBT) for substance use and <med>anxiety</med>, paired with <med>Depression</med> screening for potential dual diagnosis.  \n4. **Medical evaluation**: Neurological screening for substance-related cognitive deficits (Q16, Q15) and primary care for unexplained somatic complaints (Q10).  \n5. **Support systems**: Engage peer support groups (e.g., SMART Recovery) and family therapy to address social withdrawal (Q20\u2013Q21.  \n6. **Medication review**: Assess for nonmedical pill use (Q23) and screen for underlying conditions (e.g., ADHD, trauma) that might drive substance-seeking behaviors.  \n\nThis is a team effort\u2014we\u2019ll prioritize stabilizing your substance use while addressing the emotional and cognitive challenges you\u2019re facing. You don\u2019t have to navigate this alone.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "substance_abuse",
    "question_count": 23,
    "duration": 30676.143028974533,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 5.091763973236084,
    "diagnosis_generation_time": 8.293910026550293,
    "rag_evaluation_time": 1.1920928955078125e-05,
    "total_time": 13.385696172714233
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7251,
        "average_score": 0.7251,
        "example_excerpt": "ssive thoughts, feelings, and behaviors related \nto their illness, and that these individuals may qu...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"mental\", \"behaviors\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-Schizophrenia.pdf": {
        "access_count": 1,
        "highest_score": 0.6944,
        "average_score": 0.6944,
        "example_excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"that\", \"risk\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Conduct-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6871,
        "average_score": 0.6871,
        "example_excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"disorder\", \"dsm\" matching aspects of your query."
      },
      "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6841,
        "average_score": 0.6841,
        "example_excerpt": "ory strategies and accommodations to help maintain independence and \nperform activities of daily liv...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"neurocognitive\", \"may\", \"that\", and 3 more matching aspects of your query."
      },
      "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6765,
        "average_score": 0.6765,
        "example_excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"clinical\", \"this\", and 5 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 08:02:14",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 08:02:13",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 5,
        "clinical_relevance": 4,
        "consistency": 5,
        "diagnostic_justification": 5,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The therapist systematically addressed all 23 dimensions from the DSM-5 Level1 Cross-Cutting measure with appropriate depth. Each question was followed up when needed, and no dimensions were skipped. The therapist explored depression, anxiety, mania, psychosis, substance use, sleep, and other domains thoroughly.",
        "clinical_relevance": "The therapist's questions generally align with DSM-5 criteria, but there were slight inaccuracies or vague phrasing in a few instances. For example, when asking about 'sleeping less than usual,' the therapist could have more precisely defined 'usual' to align with DSM-5 terminology.",
        "consistency": "The dialogue flows logically, with each question naturally following from previous responses. The therapist effectively followed up on concerning disclosures, such as the patient's suicidal ideation and substance use, ensuring a coherent conversational arc.",
        "diagnostic_justification": "The diagnoses clearly align with DSM-5 responses, and the reasoning behind each diagnostic decision is explicitly stated and clinically sound. The therapist linked specific symptoms mentioned by the patient to DSM-5 criteria, providing a comprehensive differential diagnosis consideration.",
        "empathy": "The therapist responses mostly show empathy and a natural conversational style, but there were minor unnatural or robotic moments. For example, when discussing suicidal ideation, the therapist could have offered more emotional validation and support."
      },
      "overall_comments": "Overall, the therapist demonstrated a strong understanding of the DSM-5 Level1 Cross-Cutting Symptom Measure and effectively explored all relevant dimensions. The conversation flowed logically, and diagnostic justifications were clear and clinically sound. While there were minor areas for improvement, such as more precise language and emotional validation, the therapist's performance was generally excellent.",
      "average_score": 4.6,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 5,
        "explanation": "The diagnosis explicitly mentions Substance Use Disorder (Moderate/Severe, polysubstance) as the primary condition, which aligns with the expected profile of substance_abuse. The diagnosis highlights compulsive use, blackouts, and continued use despite harm, meeting DSM-5 criteria for Substance Use Disorder.",
        "classification": "substance_abuse"
      },
      "diagnosis_classification": {
        "expected_profile": "substance_abuse",
        "classified_as": "substance_abuse",
        "match": true,
        "confidence": 5
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.041804075241089
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5214953973264163,
        "local_coherence": 0.5527948131541133,
        "window_coherence": 0.5702608882515577
      },
      "readability": {
        "flesch_kincaid_grade": 8.18,
        "gunning_fog_index": 4.06,
        "flesch_reading_ease": 54.11
      },
      "diversity": {
        "distinct_1": 0.5314748201438849,
        "distinct_2": 0.9045904590459046,
        "distinct_3": 0.9747747747747748
      }
    },
    "diagnosis_evaluation": {
      "expected": "substance_abuse",
      "predicted": "Your responses highlight a complex interplay of emotional distress, substance use, and self-reported struggles with identity and connection. You\u2019ve shared feelings of emptiness, using substances to cope with anxiety or low mood, and a sense of losing touch with yourself, which sounds deeply isolating. It\u2019s clear you\u2019re navigating significant challenges, and your honesty about these struggles reflects courage. I\u2019m here to support you in understanding these patterns and exploring ways to address them safely.  \n\n**Diagnosis:** <med>Substance Use Disorder (Moderate/Severe, polysubstance)</med>, <sym>anxiety disorder (likely substance-related)</sym>, <sym>depressive symptoms (possibly substance-induced)</sym>, and <sym>cognitive impairment</sym> secondary to substance use.  \n\n**Reasoning:**  \nThe patient\u2019s polysubstance use (alcohol, cannabis, nonmedical pills) meets DSM-5 criteria for <med>Substance Use Disorder</med> due to compulsive use (Q17\u2013Q18), blackouts (Q16), and continued use despite harm (Q15, Q20). <sym>Depressive symptoms (anhedonia, hopelessness) and <sym>anxiety</sym> appear exacerbated or maintained by substance use (Q2: \u201cdrink to feel better\u201d; Q7), consistent with substance-induced mood disturbances. Denial of severity (Q22\u2013Q24) and blackouts suggest <med>Substance Use Disorder</med> is the primary driver of dysfunction, though comorbid <sym>mood dysregulation</sym> and <sym>cognitive deficits</sym> require monitoring.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate <med>Substance Use Disorder</med> evaluation**: Initiate <quote>\u201cI\u2019m trying to quit\u201d</quote> but need formal assessment for detox, withdrawal management, and motivational enhancement therapy.  \n2. **Suicide risk stabilization**: Assess <sym>passive suicidal ideation</sym> (Q12) with safety plan development and crisis resources.  \n3. **Integrated therapy**: Cognitive Behavioral Therapy (CBT) for substance use and <med>anxiety</med>, paired with <med>Depression</med> screening for potential dual diagnosis.  \n4. **Medical evaluation**: Neurological screening for substance-related cognitive deficits (Q16, Q15) and primary care for unexplained somatic complaints (Q10).  \n5. **Support systems**: Engage peer support groups (e.g., SMART Recovery) and family therapy to address social withdrawal (Q20\u2013Q21.  \n6. **Medication review**: Assess for nonmedical pill use (Q23) and screen for underlying conditions (e.g., ADHD, trauma) that might drive substance-seeking behaviors.  \n\nThis is a team effort\u2014we\u2019ll prioritize stabilizing your substance use while addressing the emotional and cognitive challenges you\u2019re facing. You don\u2019t have to navigate this alone.",
      "matches": false,
      "classification": "substance_abuse",
      "classification_confidence": 5
    }
  }
}